Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal de Groote

Showing results (41-50 of 156) with videos related to

Pageof 16
Sort By:
Plos One|November 28, 2017
Long-term prognostic impact of left ventricular remodeling after a first myocardial infarction in modern clinical practiceChristophe Bauters, Emilie Dubois, Sina Porouchani, et al.
American Heart Journal|September 26, 2006
The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patientsPascal de Groote, Nicolas Lamblin, Nicole Helbecque, et al.
International Journal of Cardiology|January 11, 2015
Percutaneous transaortic valve implantation for severe aortic regurgitation in a patient with a porto-pulmonary hypertensionEléonore Hebbar, Marie Fertin, Cédric Delhaye, et al.
European Heart Journal|April 16, 2004
Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunctionFrédérique Mizon-Gérard, Pascal de Groote, Nicolas Lamblin, et al.
American Heart Journal|August 9, 2005
Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failureNicolas Lamblin, Sophie Susen, Joël Dagorn, et al.
Chest|October 14, 2003
Aspirin does not adversely affect survival in patients with stable congestive heart failure treated with Angiotensin-converting enzyme inhibitorsValérie Aumégeat, Nicolas Lamblin, Pascal de Groote, et al.
American Heart Journal|August 17, 2004
Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?Pascal de Groote, Benoît Soudan, Nicolas Lamblin, et al.
Plos One|April 24, 2015
Multimarker proteomic profiling for the prediction of cardiovascular mortality in patients with chronic heart failureGilles Lemesle, Fleur Maury, Olivia Beseme, et al.
International Journal of Cardiology|July 17, 2012
Expanding the phenotype associated with a desmoplakin dominant mutation: Carvajal/Naxos syndrome associated with leukonychia and oligodontiaStéphane Boulé, Veronique Fressart, Daniela Laux, et al.
Archives of Cardiovascular Diseases|April 30, 2015
Sildenafil in heart transplant candidates with pulmonary hypertensionPascal de Groote, Ciham El Asri, Marie Fertin, et al.
Pageof 16

Showing results (41-50 of 156) with videos related to

Sort By:
Pageof 16
Plos One|November 28, 2017
Long-term prognostic impact of left ventricular remodeling after a first myocardial infarction in modern clinical practiceChristophe Bauters, Emilie Dubois, Sina Porouchani, et al.
American Heart Journal|September 26, 2006
The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patientsPascal de Groote, Nicolas Lamblin, Nicole Helbecque, et al.
International Journal of Cardiology|January 11, 2015
Percutaneous transaortic valve implantation for severe aortic regurgitation in a patient with a porto-pulmonary hypertensionEléonore Hebbar, Marie Fertin, Cédric Delhaye, et al.
European Heart Journal|April 16, 2004
Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunctionFrédérique Mizon-Gérard, Pascal de Groote, Nicolas Lamblin, et al.
American Heart Journal|August 9, 2005
Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failureNicolas Lamblin, Sophie Susen, Joël Dagorn, et al.
Chest|October 14, 2003
Aspirin does not adversely affect survival in patients with stable congestive heart failure treated with Angiotensin-converting enzyme inhibitorsValérie Aumégeat, Nicolas Lamblin, Pascal de Groote, et al.
American Heart Journal|August 17, 2004
Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?Pascal de Groote, Benoît Soudan, Nicolas Lamblin, et al.
Plos One|April 24, 2015
Multimarker proteomic profiling for the prediction of cardiovascular mortality in patients with chronic heart failureGilles Lemesle, Fleur Maury, Olivia Beseme, et al.
International Journal of Cardiology|July 17, 2012
Expanding the phenotype associated with a desmoplakin dominant mutation: Carvajal/Naxos syndrome associated with leukonychia and oligodontiaStéphane Boulé, Veronique Fressart, Daniela Laux, et al.
Archives of Cardiovascular Diseases|April 30, 2015
Sildenafil in heart transplant candidates with pulmonary hypertensionPascal de Groote, Ciham El Asri, Marie Fertin, et al.
Pageof 16